奥翔药业：公司将持续深化国际业务布局

Core Viewpoint - The company, Aoxiang Pharmaceutical (603229), is actively expanding its international business presence, focusing on increasing market penetration in Europe, America, Japan, and South Korea [1] Group 1 - The company's products are exported to various countries and regions, including Europe, America, Japan, and South Korea [1] - Aoxiang Pharmaceutical aims to deepen its international business layout [1] - The company is committed to enhancing its international market penetration rate [1]